ARCHIVES

Pre-Emptive Treatment Helped Curtail Panitumumab Toxicity

This article is from The Cancer Letter archive.

Vol. 32 No. 1 | January 30, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Robert Miller To Head International Affairs Office’ Pitot: No Basis for 20% Estimate

December 1, 1978

FOCR Report Offers Recommendations, Definitions for CER

May 22, 2009

NCI Amends FCRF RFP, Extends Deadline To Nov. 10

August 22, 1986

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

August 26, 2005

Consensus conference On Cervical Cancer

January 26, 1996

Panitumumab Improves PFS In Metastatic Colon Cancer

April 28, 2006